| US7198046B1 (en)* | 1991-11-14 | 2007-04-03 | Wake Forest University Health Sciences | Wound treatment employing reduced pressure |
| US7077822B1 (en)* | 1994-02-09 | 2006-07-18 | The University Of Iowa Research Foundation | Stereotactic hypothalamic obesity probe |
| US5941868A (en)* | 1995-12-22 | 1999-08-24 | Localmed, Inc. | Localized intravascular delivery of growth factors for promotion of angiogenesis |
| US7033598B2 (en)* | 1996-11-19 | 2006-04-25 | Intrabrain International N.V. | Methods and apparatus for enhanced and controlled delivery of a biologically active agent into the central nervous system of a mammal |
| US7048716B1 (en) | 1997-05-15 | 2006-05-23 | Stanford University | MR-compatible devices |
| US6272370B1 (en) | 1998-08-07 | 2001-08-07 | The Regents Of University Of Minnesota | MR-visible medical device for neurological interventions using nonlinear magnetic stereotaxis and a method imaging |
| US5957912A (en)* | 1998-04-16 | 1999-09-28 | Camino Neurocare, Inc. | Catheter having distal stylet opening and connector |
| US8465425B2 (en) | 1998-04-30 | 2013-06-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US8688188B2 (en) | 1998-04-30 | 2014-04-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US9066695B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US8346337B2 (en) | 1998-04-30 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US8974386B2 (en) | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US6949816B2 (en)* | 2003-04-21 | 2005-09-27 | Motorola, Inc. | Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same |
| US8480580B2 (en) | 1998-04-30 | 2013-07-09 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
| US6463317B1 (en) | 1998-05-19 | 2002-10-08 | Regents Of The University Of Minnesota | Device and method for the endovascular treatment of aneurysms |
| DE69928924T2 (en) | 1998-05-21 | 2006-09-28 | The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services | CANNULA FOR THE SELECTIVE PRESSURE-DEPENDENT ADMINISTRATION OF THERAPEUTIC SUBSTANCES |
| EP1621625B1 (en)* | 1998-05-27 | 2009-05-13 | Genzyme Corporation | AAV vectors for the manufacture of medicaments for convection enhanced delivery |
| ES2257051T3 (en) | 1998-05-27 | 2006-07-16 | Avigen, Inc. | ADMINISTRATION POTENTIATED BY CONVECTION OF AAV VECTORS CODING AADC. |
| US6298259B1 (en) | 1998-10-16 | 2001-10-02 | Univ Minnesota | Combined magnetic resonance imaging and magnetic stereotaxis surgical apparatus and processes |
| US6221349B1 (en) | 1998-10-20 | 2001-04-24 | Avigen, Inc. | Adeno-associated vectors for expression of factor VIII by target cells |
| US6200560B1 (en)* | 1998-10-20 | 2001-03-13 | Avigen, Inc. | Adeno-associated virus vectors for expression of factor VIII by target cells |
| US7670327B2 (en)* | 2000-01-20 | 2010-03-02 | Regents Of The University Of Minnesota | Catheter systems for delivery of agents and related method thereof |
| US6549803B1 (en) | 2000-05-08 | 2003-04-15 | Image-Guided Neurologics Inc. | Method and apparatus for targeting material delivery to tissue |
| US6540655B1 (en) | 2000-11-10 | 2003-04-01 | Scimed Life Systems, Inc. | Miniature x-ray unit |
| US6546080B1 (en)* | 2000-11-10 | 2003-04-08 | Scimed Life Systems, Inc. | Heat sink for miniature x-ray unit |
| US6554757B1 (en) | 2000-11-10 | 2003-04-29 | Scimed Life Systems, Inc. | Multi-source x-ray catheter |
| US6551278B1 (en)* | 2000-11-10 | 2003-04-22 | Scimed Life Systems, Inc. | Miniature x-ray catheter with retractable needles or suction means for positioning at a desired site |
| US6540720B1 (en)* | 2000-11-10 | 2003-04-01 | Scimed Life Systems, Inc. | Miniature x-ray unit |
| US20040053849A1 (en)* | 2000-12-20 | 2004-03-18 | Bair Kenneth Walter | Inhibitors of the E2F-1/cyclin interaction for cancer therapy |
| US20020142966A1 (en)* | 2000-12-20 | 2002-10-03 | Bair Kenneth Walter | Inhibitors of the E2F-1/cyclin interaction for cancer therapy |
| US6560471B1 (en) | 2001-01-02 | 2003-05-06 | Therasense, Inc. | Analyte monitoring device and methods of use |
| US7098374B2 (en) | 2001-02-09 | 2006-08-29 | University Of Florida Research Foundation, Inc. | Human disease modeling using somatic gene transfer |
| US20030118585A1 (en)* | 2001-10-17 | 2003-06-26 | Agy Therapeutics | Use of protein biomolecular targets in the treatment and visualization of brain tumors |
| US20030050273A1 (en)* | 2001-08-29 | 2003-03-13 | Keiya Ozawa | Compositions and methods for treating neurodegenerative diseases |
| US6893429B2 (en)* | 2001-08-30 | 2005-05-17 | Medtronic, Inc. | Convection enhanced delivery catheter to treat brain and other tumors |
| US6974448B2 (en) | 2001-08-30 | 2005-12-13 | Medtronic, Inc. | Method for convection enhanced delivery catheter to treat brain and other tumors |
| CA2466443A1 (en)* | 2001-11-09 | 2003-05-15 | Neopharm, Inc. | Selective treatment of il-13 expressing tumors |
| DE50107066D1 (en) | 2001-11-30 | 2005-09-15 | Brainlab Ag | Device for planning an infusion |
| US6758828B2 (en) | 2001-12-10 | 2004-07-06 | Regents Of The University Of Minnesota | Catheter for cell delivery in tissue |
| US6846484B2 (en)* | 2001-12-28 | 2005-01-25 | Regents Of The University Of Minnesota | DTAT fusion toxin |
| US20030171738A1 (en)* | 2002-03-06 | 2003-09-11 | Konieczynski David D. | Convection-enhanced drug delivery device and method of use |
| US7108680B2 (en)* | 2002-03-06 | 2006-09-19 | Codman & Shurtleff, Inc. | Closed-loop drug delivery system |
| US20040006259A1 (en)* | 2002-06-19 | 2004-01-08 | Christoph Pedain | Method and device for determining migration pathways of cells |
| EP1376443A1 (en)* | 2002-06-19 | 2004-01-02 | BrainLAB AG | Method and device for determining the migration ways of cells |
| EP1398641B1 (en) | 2002-09-12 | 2006-10-18 | BrainLAB AG | Determination of distributions for the planning of infusions |
| AU2003299140B2 (en)* | 2002-09-24 | 2008-07-17 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method for convection enhanced delivery of therapeutic agents |
| SI2891666T1 (en) | 2002-10-16 | 2017-11-30 | Purdue Pharma L.P. | Antibodies that bind cell-associated CA 125/O722P and methods of use thereof |
| US7618948B2 (en)* | 2002-11-26 | 2009-11-17 | Medtronic, Inc. | Devices, systems and methods for improving and/or cognitive function through brain delivery of siRNA |
| US7605249B2 (en)* | 2002-11-26 | 2009-10-20 | Medtronic, Inc. | Treatment of neurodegenerative disease through intracranial delivery of siRNA |
| US7829694B2 (en)* | 2002-11-26 | 2010-11-09 | Medtronic, Inc. | Treatment of neurodegenerative disease through intracranial delivery of siRNA |
| WO2004058334A1 (en)* | 2002-12-23 | 2004-07-15 | Medtronic, Inc. | Implantable drug delivery systems and methods |
| US8246602B2 (en)* | 2002-12-23 | 2012-08-21 | Medtronic, Inc. | Catheters with tracking elements and permeable membranes |
| US8043281B2 (en)* | 2002-12-23 | 2011-10-25 | Medtronic, Inc. | Catheters incorporating valves and permeable membranes |
| US7732591B2 (en)* | 2003-11-25 | 2010-06-08 | Medtronic, Inc. | Compositions, devices and methods for treatment of huntington's disease through intracranial delivery of sirna |
| US7994149B2 (en) | 2003-02-03 | 2011-08-09 | Medtronic, Inc. | Method for treatment of Huntington's disease through intracranial delivery of sirna |
| US8290579B2 (en)* | 2003-02-19 | 2012-10-16 | Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. | Device, methods and sponges for iontophoretic drug delivery |
| US8946151B2 (en)* | 2003-02-24 | 2015-02-03 | Northern Bristol N.H.S. Trust Frenchay Hospital | Method of treating Parkinson's disease in humans by convection-enhanced infusion of glial cell-line derived neurotrophic factor to the putamen |
| WO2004087758A2 (en)* | 2003-03-26 | 2004-10-14 | Neopharm, Inc. | Il 13 receptor alpha 2 antibody and methods of use |
| US7963956B2 (en) | 2003-04-22 | 2011-06-21 | Antisense Pharma Gmbh | Portable equipment for administration of fluids into tissues and tumors by convection enhanced delivery technique |
| EP1649062B1 (en)* | 2003-07-03 | 2009-12-09 | Gentron, LLC. | Methods and systems for diagnosis of non-central nervous system (cns) diseases in cns samples |
| US20050137579A1 (en)* | 2003-12-23 | 2005-06-23 | Medtronic, Inc. | Permeable membrane catheters, systems, and methods |
| US7848543B2 (en)* | 2004-02-05 | 2010-12-07 | Brainlab Ag | Method and system for prediction and management of material and information transport in an organism |
| US20050208090A1 (en)* | 2004-03-18 | 2005-09-22 | Medtronic, Inc. | Methods and systems for treatment of neurological diseases of the central nervous system |
| US7727225B2 (en)* | 2004-07-28 | 2010-06-01 | University Of Virginia Patent Foundation | Coaxial catheter systems for transference of medium |
| US8391959B2 (en)* | 2004-09-29 | 2013-03-05 | Tel Hashomer Medical Research Infrastructure And Services Ltd. | Composition for improving efficiency of drug delivery |
| BRPI0516463B1 (en)* | 2004-10-05 | 2021-05-11 | Genzyme Corporation | delivery system for one or more materials |
| US9907485B2 (en)* | 2004-10-15 | 2018-03-06 | Brainlab Ag | Targeted immunization and plaque destruction against Alzheimer's disease |
| US9924888B2 (en)* | 2004-10-15 | 2018-03-27 | Brainlab Ag | Targeted infusion of agents against parkinson's disease |
| US9901413B2 (en)* | 2004-10-15 | 2018-02-27 | Brainlab Ag | Targeted infusion of agents for treatment of ALS |
| US7367944B2 (en)* | 2004-12-13 | 2008-05-06 | Tel Hashomer Medical Research Infrastructure And Services Ltd. | Method and system for monitoring ablation of tissues |
| US20060253068A1 (en)* | 2005-04-20 | 2006-11-09 | Van Bilsen Paul | Use of biocompatible in-situ matrices for delivery of therapeutic cells to the heart |
| EP1885854B1 (en)* | 2005-05-06 | 2012-10-17 | Medtronic, Inc. | Methods and sequences to suppress primate huntington gene expression |
| US7902352B2 (en)* | 2005-05-06 | 2011-03-08 | Medtronic, Inc. | Isolated nucleic acid duplex for reducing huntington gene expression |
| US20080280843A1 (en)* | 2006-05-24 | 2008-11-13 | Van Bilsen Paul | Methods and kits for linking polymorphic sequences to expanded repeat mutations |
| US9133517B2 (en)* | 2005-06-28 | 2015-09-15 | Medtronics, Inc. | Methods and sequences to preferentially suppress expression of mutated huntingtin |
| EP2322657B1 (en)* | 2005-06-28 | 2014-11-05 | Medtronic, Inc. | Methods and sequences to preferentially suppress expression of mutated huntingtin gene. |
| JP5238503B2 (en) | 2005-08-23 | 2013-07-17 | ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア | Anti-reflux cannula and system for chronic delivery of therapeutic agents using enhanced convection delivery |
| US7713232B2 (en)* | 2005-11-04 | 2010-05-11 | Medrad, Inc. | System for washing and processing of cells for delivery thereof to tissue |
| US8182444B2 (en)* | 2005-11-04 | 2012-05-22 | Medrad, Inc. | Delivery of agents such as cells to tissue |
| MX2008006313A (en) | 2005-11-15 | 2008-11-06 | Philadelphia Children Hospital | Reactive dyestuffs, method for the production thereof, and use of the same. |
| EP1788498A1 (en)* | 2005-11-21 | 2007-05-23 | BrainLAB AG | Apparatus for infusing substances |
| DK1969003T3 (en) | 2005-12-14 | 2010-12-13 | Hermo Pharma Ltd | Applications of a neurotrophic factor protein |
| AR059089A1 (en) | 2006-01-20 | 2008-03-12 | Genzyme Corp | INTRAVENTRICULAR ADMINISTRATION OF AN ENZYME FOR LISOSOMAL STORAGE DISEASES |
| WO2007095056A2 (en)* | 2006-02-09 | 2007-08-23 | Genzyme Corporation | Slow intraventricular delivery |
| AU2007220825B2 (en) | 2006-02-23 | 2013-02-21 | The Children's Hospital Of Philadelphia | Compositions and methods for modulating hemostasis using variant forms of activated Factor V |
| WO2007127803A2 (en)* | 2006-04-25 | 2007-11-08 | The Regents Of The University Of California | Administration of growth factors for the treatment of cns disorders |
| WO2007127839A2 (en)* | 2006-04-26 | 2007-11-08 | The Regents Of The University Of California | Compositions and methods for convection enhanced delivery of high molecular weight neurotherapeutics |
| US9273356B2 (en) | 2006-05-24 | 2016-03-01 | Medtronic, Inc. | Methods and kits for linking polymorphic sequences to expanded repeat mutations |
| JP2010500103A (en)* | 2006-08-08 | 2010-01-07 | ピーク バイオサイエンシーズ， インコーポレイテッド | Catheters and arrays for anti-cancer treatment |
| WO2008033285A2 (en)* | 2006-09-15 | 2008-03-20 | The Trustees Of Culumbia University In The City Of New York | Delivery of double-stranded rna into the central nervous system |
| EP1905466B1 (en)* | 2006-09-28 | 2017-05-31 | Brainlab AG | Identification of an infusion region in the heterogeneous tissue |
| US20080086111A1 (en)* | 2006-10-09 | 2008-04-10 | Medrad, Inc. | Fluid delivery systems and volume metering in cell delivery |
| US7794443B2 (en)* | 2006-10-24 | 2010-09-14 | Medtronic, Inc. | System and method for intraparenchymal drug infusion |
| US7988674B2 (en)* | 2006-10-30 | 2011-08-02 | Medtronic, Inc. | Externally releasable body portal anchors and systems |
| US8324367B2 (en) | 2006-11-03 | 2012-12-04 | Medtronic, Inc. | Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity |
| US9375440B2 (en)* | 2006-11-03 | 2016-06-28 | Medtronic, Inc. | Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity |
| US7931651B2 (en) | 2006-11-17 | 2011-04-26 | Wake Lake University Health Sciences | External fixation assembly and method of use |
| US7819842B2 (en)* | 2006-11-21 | 2010-10-26 | Medtronic, Inc. | Chronically implantable guide tube for repeated intermittent delivery of materials or fluids to targeted tissue sites |
| US7988668B2 (en)* | 2006-11-21 | 2011-08-02 | Medtronic, Inc. | Microsyringe for pre-packaged delivery of pharmaceuticals |
| US7744559B2 (en)* | 2006-12-19 | 2010-06-29 | Cytyc Corporation | Systems and methods for drug infusion with feedback control |
| US8377016B2 (en) | 2007-01-10 | 2013-02-19 | Wake Forest University Health Sciences | Apparatus and method for wound treatment employing periodic sub-atmospheric pressure |
| US20080171906A1 (en)* | 2007-01-16 | 2008-07-17 | Everaerts Frank J L | Tissue performance via hydrolysis and cross-linking |
| WO2008100930A2 (en) | 2007-02-13 | 2008-08-21 | Cornell University | Convection enhanced delivery apparatus, method and application |
| US20110135569A1 (en)* | 2007-03-20 | 2011-06-09 | Peak Biosciences Inc. | Method for therapeutic administration of radionucleosides |
| EP2152874A2 (en) | 2007-04-26 | 2010-02-17 | University of Iowa Research Foundation | Rna interference suppression of neurodegenerative diseases and methods of use thereof |
| US8470295B2 (en)* | 2007-05-10 | 2013-06-25 | Peak Biosciences, Inc. | Methods of treatment of androgenic steroidal hormone dependent cancer with auger electron-emitting nucleoside analogs |
| EP1992957B1 (en) | 2007-05-16 | 2013-01-02 | BrainLAB AG | Method for estimating the physiological parameters defining the edema induced upon infusion of fluid from an intraparenchymally placed catheter |
| CA2688825C (en) | 2007-05-17 | 2016-06-28 | Medgenesis Therapeutix Inc. | Convection-enhanced delivery catheter with removable stiffening member and method for using same |
| CA2687330A1 (en) | 2007-05-18 | 2008-11-27 | The Johns Hopkins University | A treatment simulator for brain diseases and method of use thereof |
| AU2008260103B2 (en)* | 2007-05-31 | 2014-04-03 | University Of Iowa Research Foundation | Reduction of off-target RNA interference toxicity |
| CA2697363A1 (en)* | 2007-08-23 | 2009-03-05 | The Board Of Trustees Of The Leland Stanford Junior University | Modulation of synaptogenesis |
| US8147480B2 (en) | 2007-09-28 | 2012-04-03 | Codman & Shurtleff, Inc. | Catheter for reduced reflux in targeted tissue delivery of a therapeutic agent |
| US7766875B2 (en)* | 2007-09-28 | 2010-08-03 | Codman & Shurtleff, Inc. | Catheter for reduced reflux in targeted tissue delivery of a therapeutic agent |
| KR101600041B1 (en) | 2007-10-10 | 2016-03-03 | 웨이크 포리스트 유니버시티 헬스 사이언시즈 | Devices and methods for treating spinal cord tissue |
| FI20070808A0 (en) | 2007-10-25 | 2007-10-25 | Mart Saarma | Split variants of GDNF and uses thereof |
| US8480626B2 (en)* | 2007-11-30 | 2013-07-09 | Medtronic, Inc. | Infusion catheter assembly with reduced backflow |
| RU2517588C2 (en) | 2008-01-09 | 2014-05-27 | Уэйк Форест Юниверсити Хелс Сайенсиз | Device and method for treating pathologies of central nervous system |
| US9002076B2 (en)* | 2008-04-15 | 2015-04-07 | Medtronic, Inc. | Method and apparatus for optimal trajectory planning |
| FI20080326A0 (en) | 2008-04-30 | 2008-04-30 | Licentia Oy | Neurotrophic factor MANF and its uses |
| ES2633142T3 (en) | 2008-07-18 | 2017-09-19 | Wake Forest University Health Sciences | Apparatus for modulation of cardiac tissue through topical application of vacuum to minimize death and cell damage |
| EP2365822B1 (en) | 2008-11-21 | 2015-07-01 | The Children's Hospital Of Philadelphia | Snake factor v and methods of use as a procoagulant |
| ES2488820T3 (en)* | 2009-01-12 | 2014-08-29 | Becton Dickinson And Company | Intracranial catheters optimized for administration of convection-enhanced therapeutic agents |
| WO2010088560A1 (en) | 2009-01-29 | 2010-08-05 | University Of California, San Francisco | Methods for distributing high levels of therapeutic agent throughout the cortex to treat neurological disorders |
| US8335552B2 (en)* | 2009-03-20 | 2012-12-18 | Medtronic, Inc. | Method and apparatus for instrument placement |
| US10105485B2 (en) | 2010-04-16 | 2018-10-23 | MRI Interventions, Inc. | MRI surgical systems including MRI-compatible surgical cannulae for transferring a substance to and/or from a patient |
| CA2827380C (en) | 2011-02-12 | 2020-08-25 | University Of Iowa Research Foundation | Therapeutic nucleic acids |
| CA2843587C (en) | 2011-08-01 | 2020-03-24 | Alcyone Lifesciences, Inc. | Microfluidic drug delivery devices |
| US9371522B2 (en) | 2011-09-30 | 2016-06-21 | The Children's Hospital Of Philadelphia | Compositions and methods for modulating hemostasis |
| ES2869328T3 (en) | 2012-12-18 | 2021-10-25 | Alcyone Lifesciences Inc | Devices and methods for reducing or preventing reflux in an administration system |
| US9320851B2 (en) | 2013-02-07 | 2016-04-26 | Medizinische Universitaet Graz | Infusion arrangement and method |
| GB201308917D0 (en)* | 2013-05-17 | 2013-07-03 | Renishaw Plc | Delivery |
| WO2014191630A2 (en) | 2013-05-28 | 2014-12-04 | Helsingin Yliopisto | Non-human animal model encoding a non-functional manf gene |
| CA3120114A1 (en) | 2013-06-17 | 2014-12-24 | Alcyone Lifesciences, Inc. | Methods and devices for protecting catheter tips and stereotactic fixtures for microcatheters |
| CA2920014C (en) | 2013-07-31 | 2021-11-09 | Alcyone Lifesciences, Inc. | Systems and methods for drug delivery, treatment, and monitoring |
| US9891296B2 (en) | 2013-09-13 | 2018-02-13 | MRI Interventions, Inc. | Intrabody fluid transfer devices, systems and methods |
| EP3140429B1 (en) | 2014-05-05 | 2020-02-19 | Medtronic Inc. | Methods for scd, crt, crt-d, or sca therapy identification and/or selection |
| EP3146051B8 (en) | 2014-05-20 | 2019-11-27 | University of Iowa Research Foundation | Huntington's disease therapeutic compounds |
| US10806396B2 (en) | 2015-01-26 | 2020-10-20 | Alcyone Lifesciences, Inc. | Drug delivery methods with tracer |
| US10898548B2 (en) | 2015-01-29 | 2021-01-26 | Leuvas Therapeutics | Modulators of protein tyrosine phosphatase and uses thereof |
| US10377818B2 (en) | 2015-01-30 | 2019-08-13 | The Board Of Trustees Of The Leland Stanford Junior University | Method of treating glioma |
| US10883117B2 (en) | 2015-03-24 | 2021-01-05 | The Regents Of The University Of California | Adeno-associated virus variants and methods of use thereof |
| PE20231949A1 (en) | 2015-10-30 | 2023-12-05 | Spark Therapeutics Inc | VARIANTS OF FACTOR VIII REDUCED WITH CpG, COMPOSITIONS AND METHODS AND USES FOR THE TREATMENT OF HEMOSTASY DISORDERS |
| JP2019502473A (en) | 2016-01-04 | 2019-01-31 | アルキオーネ・ライフサイエンシズ・インコーポレイテッドＡｌｃｙｏｎｅ Ｌｉｆｅｓｃｉｅｎｃｅｓ， Ｉｎｃ． | Method and apparatus for treating stroke |
| US9758786B2 (en) | 2016-02-09 | 2017-09-12 | Autotelic, Llc | Compositions and methods for treating pancreatic cancer |
| EP3393571B1 (en) | 2016-02-17 | 2024-03-06 | ClearPoint Neuro, Inc. | Intrabody surgical fluid transfer assemblies with adjustable exposed cannula to needle tip length, related systems and methods |
| EP3454943A4 (en) | 2016-05-11 | 2020-01-15 | Leuvas Therapeutics | BLOCKING TIM-1 PATHS AND P-SELECTIN PATHS IN THE TREATMENT OF NEUROINFLAMMATORY DEGENERATIVE DISEASES |
| US20190151239A1 (en) | 2016-07-28 | 2019-05-23 | Cerebral Therapeutics LLC | Infusing drug solution directly into brain fluid |
| EP3490653B1 (en)* | 2016-07-28 | 2025-08-27 | Biogen MA Inc. | Implantable intraventricular sampling and infusion access device |
| US11723865B2 (en) | 2017-02-08 | 2023-08-15 | New Hope Research Foundation, Inc. | Systems and methods for enhanced distribution of a biologic agent within the brain and spinal cord |
| US11541005B2 (en) | 2017-02-08 | 2023-01-03 | New Hope Research Foundation, Inc. | Systems and methods for enhanced distribution of a biologic agent within the brain and spinal cord |
| US20210228738A1 (en) | 2017-07-17 | 2021-07-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulins |
| EP3746065A4 (en) | 2018-01-29 | 2022-02-16 | Cognos Therapeutics Inc. | INTRATUMORAL ADMINISTRATION OF BORTEZOMIB |
| US11730767B2 (en) | 2018-02-23 | 2023-08-22 | Regeneration Biomedical, Inc. | Methods, apparatuses and systems for instilling stem cells and pharmaceuticals into the human ventricular system |
| US11253237B2 (en) | 2018-05-09 | 2022-02-22 | Clearpoint Neuro, Inc. | MRI compatible intrabody fluid transfer systems and related devices and methods |
| EP3781074A1 (en) | 2018-05-09 | 2021-02-24 | ClearPoint Neuro, Inc. | Mri compatible intrabody fluid transfer systems and related devices and methods |
| WO2020092937A1 (en) | 2018-11-02 | 2020-05-07 | Annexon, Inc. | Compositions and methods for treating brain injury |
| US11684750B2 (en) | 2019-10-08 | 2023-06-27 | Clearpoint Neuro, Inc. | Extension tube assembly and related medical fluid transfer systems and methods |
| CN110585577B (en)* | 2019-10-16 | 2022-02-08 | 云南省第一人民医院 | A device of dosing is intervene in environmental protection for treating liver cancer |
| US20230127134A1 (en)* | 2021-09-20 | 2023-04-27 | Droplet Biosciences, Inc. | Methods for cancer treatment |